GKOS - Glaukos Corp Stock Price, Fair Value and News

102.04USD+0.94 (+0.93%)Delayed as of 24 Apr 2024, 03:04 pm ET

Market Summary

USD102.04+0.94

Delayedas of 24 Apr 2024, 03:04 pm

0.93%

GKOS Alerts

2 major insider sales recently.

GKOS Stock Price

View Fullscreen

GKOS RSI Chart

GKOS Valuation

Market Cap

5.0B

Price/Earnings (Trailing)

-37.13

Price/Sales (Trailing)

15.89

EV/EBITDA

-44.08

Price/Free Cashflow

-64.12

GKOS Price/Sales (Trailing)

GKOS Profitability

EBT Margin

-42.49%

Return on Equity

-29.17%

Return on Assets

-14.32%

Free Cashflow Yield

-1.56%

GKOS Fundamentals

GKOS Revenue

Revenue (TTM)

314.7M

Rev. Growth (Yr)

15.64%

Rev. Growth (Qtr)

5.53%

GKOS Earnings

Earnings (TTM)

-134.7M

Earnings Growth (Yr)

-17.03%

Earnings Growth (Qtr)

-20.94%

Breaking Down GKOS Revenue

52 Week Range

45.38103.58

(Low)(High)

Last 7 days

4.3%

Last 30 days

14.8%

Last 90 days

9.8%

Trailing 12 Months

110.0%

How does GKOS drawdown profile look like?

GKOS Financial Health

Current Ratio

5.34

Debt/Equity

Debt/Cashflow

-75.56

GKOS Investor Care

Shares Dilution (1Y)

3.33%

Diluted EPS (TTM)

-2.78

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2023	289.1M	296.8M	303.6M	314.7M
2022	293.7M	288.3M	284.9M	282.9M
2021	237.6M	284.1M	294.0M	294.0M
2020	238.3M	211.3M	217.6M	225.0M
2019	195.2M	210.6M	225.2M	237.0M
2018	163.5M	165.4M	168.9M	181.3M
2017	127.2M	139.9M	150.8M	159.3M
2016	80.1M	90.9M	101.5M	114.4M
2015	52.0M	58.7M	65.5M	71.7M
2014	27.1M	33.3M	39.4M	45.6M
2013	0	0	0	20.9M

Get all data in R, Python etc through our Historical Stock Data APIs

Tracking the Latest Insider Buys and Sells of Glaukos Corp

Filter Transactions

Datesorted ascending	Name	Buy/Sell	$ Value	Avg. Price	# Shares	Title
Apr 10, 2024	hoffmeister david f	acquired	72,750	7.275	10,000	-
Apr 08, 2024	gilliam joseph e	acquired	2,493,100	41.69	59,801	president & coo
Apr 08, 2024	gilliam joseph e	sold	-6,008,360	100	-59,801	president & coo
Apr 08, 2024	thurman alex r.	sold	-137,944	100	-1,372	svp & chief financial officer
Apr 05, 2024	gilliam joseph e	acquired	135,577	55.18	2,457	president & coo
Apr 05, 2024	gilliam joseph e	sold	-237,862	96.81	-2,457	president & coo
Apr 05, 2024	thurman alex r.	sold	-25,316	96.6269	-262	svp & chief financial officer
Apr 04, 2024	gilliam joseph e	sold	-19,314	96.57	-200	president & coo
Apr 04, 2024	thurman alex r.	sold	-41,371	95.3253	-434	svp & chief financial officer
Apr 04, 2024	gilliam joseph e	acquired	11,036	55.18	200	president & coo

Which funds bought or sold GKOS recently?

View All Details

Datesorted ascending	Fund Name	Type	% Chg	$ Change	$ Held	% Portfolio
Apr 22, 2024	RAYMOND JAMES & ASSOCIATES	reduced	-2.62	133,787	996,174	-%
Apr 22, 2024	MetLife Investment Management, LLC	added	0.76	119,017	1,968,890	0.01%
Apr 19, 2024	Taylor Frigon Capital Management LLC	reduced	-1.00	683,268	4,603,240	2.19%
Apr 19, 2024	Valeo Financial Advisors, LLC	added	1.71	144,117	842,198	0.03%
Apr 19, 2024	TRUST POINT INC.	added	53.82	458,048	1,013,520	0.08%
Apr 19, 2024	CALDWELL SUTTER CAPITAL, INC.	added	5,860	138,505	140,492	0.07%
Apr 19, 2024	Maryland State Retirement & Pension System	reduced	-0.69	307,624	1,715,150	0.03%
Apr 19, 2024	State of Alaska, Department of Revenue	reduced	-0.94	418,000	2,803,000	0.03%
Apr 18, 2024	SteelPeak Wealth, LLC	new	-	343,122	343,122	0.02%
Apr 18, 2024	FARMERS & MERCHANTS INVESTMENTS INC	unchanged	-	503	3,206	-%

Are Funds Buying or Selling GKOS?

Are funds buying GKOS calls or puts?

Calls

Puts

No. of funds holding Calls - Puts

Net Call Options

No. of funds that own GKOS

No. of Funds

GKOS Alerts

2 major insider sales recently.

Unveiling Glaukos Corp's Major ShareHolders

Date Filed	Name of Filer	Percent of Class	No. of Shares	Form Type
Feb 14, 2024	brown capital management llc	5.53%	2,697,794	SC 13G/A
Feb 13, 2024	burns thomas william	5.08%	2,552,501	SC 13G/A
Feb 13, 2024	vanguard group inc	10.73%	5,236,738	SC 13G/A
Feb 09, 2024	fmr llc	-	0	SC 13G/A
Jan 22, 2024	blackrock inc.	16.2%	7,894,315	SC 13G/A
Jan 10, 2024	wellington management group llp	2.75%	1,340,500	SC 13G/A
Dec 11, 2023	fmr llc	-	0	SC 13G
Feb 14, 2023	burns thomas william	5.71%	2,807,641	SC 13G/A
Feb 14, 2023	brown capital management llc	5.69%	2,712,809	SC 13G/A
Feb 09, 2023	vanguard group inc	11.21%	5,349,225	SC 13G/A

Recent SEC filings of Glaukos Corp

View All Filings

Date Filed	Form Type	Document
Apr 16, 2024	ARS	ARS
Apr 16, 2024	DEF 14A	DEF 14A
Apr 16, 2024	DEFA14A	DEFA14A
Apr 12, 2024	4	Insider Trading
Apr 10, 2024	4	Insider Trading
Apr 09, 2024	4	Insider Trading
Apr 09, 2024	4	Insider Trading
Apr 08, 2024	144	Notice of Insider Sale Intent
Apr 08, 2024	144	Notice of Insider Sale Intent
Apr 05, 2024	144	Notice of Insider Sale Intent

Peers (Alternatives to Glaukos Corp)

Name	Mkt Capsorted ascending	Revenue	Price %, 1M	Returns, 1Y	P/E	P/S	Rev 1-Yr	Inc 1-Yr
LARGE-CAP
ABT	186.7B	40.1B	-2.69%	-2.54%	32.62	4.65	-8.12%	-17.45%
BDX	67.7B	19.5B	-4.86%	-10.59%	53.89	3.47	4.02%	-22.04%
ALGN	23.4B	3.9B	-2.36%	-14.10%	52.63	6.06	3.42%	23.09%
BAX	20.8B	14.8B	-2.22%	-9.67%	7.84	1.41	2.12%	209.17%
MID-CAP
HSIC	9.4B	12.3B	-0.49%	-14.47%	22.48	0.76	-2.44%	-22.68%
ATR	9.3B	3.5B	-1.02%	16.40%	32.52	2.65	4.97%	18.89%
BIO	8.3B	2.7B	-18.63%	-38.25%	-13.07	3.12	-4.68%	82.43%
XRAY	6.4B	4.0B	-5.77%	-25.53%	-47.58	1.61	1.10%	85.84%
AXNX	3.4B	366.4M	-2.62%	10.65%	-558.61	9.25	33.86%	89.83%
PDCO	2.3B	6.6B	-4.73%	-4.84%	12.02	0.35	2.78%	-0.87%
SMALL-CAP
AHCO	1.3B	3.2B	-11.22%	-19.13%	-1.92	0.41	7.73%	-1066.14%
ANIK	383.0M	166.7M	1.30%	-3.37%	-4.63	2.3	6.67%	-456.34%
ANGO	241.5M	324.0M	12.50%	-31.24%	-1.26	0.75	-3.19%	-337.41%
APYX	45.7M	52.3M	5.60%	-56.15%	-2.44	0.87	17.61%	19.28%
AEMD	4.0M	3.7M	-11.70%	184.91%	-0.32	1.06	5.77%	8.23%

Glaukos Corp News

Latest updates

Glaukos Corp Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)

(*) denotes actual numbers (not divided by Thousands)
Income Statement (Quarterly)																					(In Thousands)
Description	(%) Q/Q	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1	2018Q4
Revenue	5.5%	82,365,000	78,048,000	80,399,000	73,899,000	71,227,000	71,269,000	72,685,000	67,681,000	73,240,000	74,710,000	78,093,000	67,968,000	73,234,000	64,831,000	31,558,000	55,336,000	65,849,000	58,509,000	58,600,000	54,026,000	54,076,000
Gross Profit	6.6%	63,474,000	59,538,000	60,296,000	55,828,000	54,005,000	54,408,000	54,852,000	50,618,000	56,375,000	59,340,000	60,334,000	51,335,000	53,644,000	46,899,000	9,890,000	22,807,000	49,945,000	50,806,000	50,730,000	46,915,000	46,958,000
Operating Expenses	16.6%	102,096,000	87,548,000	89,371,000	88,821,000	87,739,000	76,019,000	91,612,000	40,826,000	74,244,000	48,316,000	74,556,000	63,140,000	65,036,000	59,251,000	57,087,000	75,419,000	79,642,000	63,221,000	56,970,000	48,855,000	45,061,000
S&GA Expenses	16.2%	63,034,000	54,247,000	53,137,000	53,650,000	51,927,000	47,149,000	49,900,000	43,949,000	47,566,000	44,470,000	45,300,000	41,921,000	43,792,000	38,947,000	38,116,000	50,546,000	59,611,000	44,443,000	37,656,000	34,925,000	32,104,000
R&D Expenses	-	-	-	-	-	-	-	-	26,877,000	-	-	-	21,219,000	-	-	-	-	-	-	-	13,930,000	12,957,000
EBITDA Margin	-1.2%	-0.35	-0.35	-0.35	-0.41	-0.28	-0.24	-0.13	-0.03	-0.11	-0.08	-0.16	-0.32	-	-	-	-	-	-	-	-	-
Interest Expenses	0.9%	3,428,000	3,398,000	3,399,000	3,408,000	3,409,000	3,481,000	3,414,000	3,416,000	3,424,000	3,413,000	3,306,000	3,229,000	-	-	-	-	-	-	-	-	-
Income Taxes	113.5%	79,000	37,000	400,000	400,000	298,000	247,000	-105,000	300,000	-363,000	202,000	208,000	279,000	-3,243,000	-889,000	-7,384,000	-450,000	-65,841,000	187,000	72,000	122,000	530,000
Earnings Before Taxes	-20.8%	-36,718,000	-30,407,000	-32,377,000	-34,225,000	-31,162,000	-27,329,000	-45,641,000	5,703,000	-22,235,000	6,432,000	-17,274,000	-16,190,000	-13,891,000	-16,637,000	-47,278,000	-54,508,000	-29,260,000	-13,319,000	-6,237,000	-1,220,000	2,309,000
EBT Margin	-0.6%	-0.42	-0.42	-0.42	-0.48	-0.35	-0.31	-0.19	-0.09	-0.17	-0.14	-0.23	-0.40	-	-	-	-	-	-	-	-	-
Net Income	-20.9%	-36,818,000	-30,444,000	-32,812,000	-34,626,000	-31,460,000	-27,576,000	-45,536,000	5,377,000	-21,872,000	6,230,000	-17,482,000	-16,469,000	-10,648,000	-15,748,000	-39,894,000	-54,058,000	36,581,000	-13,506,000	-6,309,000	-1,342,000	1,779,000
Net Income Margin	-0.5%	-0.43	-0.43	-0.43	-0.48	-0.35	-0.31	-0.19	-0.09	-0.17	-0.13	-0.21	-0.35	-	-	-	-	-	-	-	-	-
Free Cashflow	-29.1%	-14,879,000	-11,528,000	-13,927,000	-37,672,000	-12,374,000	-32,554,000	-21,607,000	3,170,000	-13,978,000	7,874,000	-3,969,000	-13,004,000	-	-	-	-	-	-	-	-	-

Balance Sheet

(In Millions)

(*) denotes actual numbers (not divided by Millions)
Balance Sheet																					(In Millions)
Description	(%) Q/Q	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1	2018Q4
Assets	-0.9%	940	949	957	973	1,002	1,008	1,031	1,052	1,050	1,064	1,044	1,023	1,006	995	996	780	818	307	302	228	207
Current Assets	-1.0%	395	400	401	416	444	449	471	491	486	502	491	474	469	454	453	231	263	209	201	184	177
Cash Equivalents	-14.2%	93.00	109	95.00	76.00	120	113	112	116	101	123	128	106	106	90.00	276	63.00	72.00	48.00	49.00	42.00	39.00
Inventory	5.5%	42.00	40.00	39.00	40.00	38.00	34.00	28.00	25.00	23.00	20.00	18.00	15.00	16.00	20.00	21.00	28.00	43.00	13.00	14.00	13.00	13.00
Net PPE	0.1%	103	103	103	98.00	94.00	87.00	81.00	75.00	69.00	61.00	54.00	43.00	24.00	23.00	23.00	23.00	22.00	20.00	20.00	20.00	19.00
Goodwill	0%	66.00	66.00	66.00	66.00	66.00	66.00	66.00	66.00	66.00	66.00	66.00	66.00	66.00	66.00	66.00	66.00	66.00	-	-	-	-
Liabilities	1.6%	479	471	468	464	472	460	469	455	463	463	459	433	338	333	333	138	145	117	114	43.00	33.00
Current Liabilities	10.2%	74.00	67.00	64.00	62.00	72.00	61.00	70.00	56.00	63.00	63.00	349	336	50.00	47.00	55.00	51.00	58.00	33.00	31.00	27.00	30.00
LT Debt, Current	-	-	-	-	-	-	-	-	-	-	-	279	279	-	-	-	-	-	-	-	-	-
Shareholder's Equity	-3.3%	462	478	489	509	530	549	562	598	587	601	584	590	667	662	662	641	673	190	188	185	174
Retained Earnings	-6.5%	-599	-562	-531	-499	-464	-432	-405	-359	-365	-343	-349	-332	-310	-299	-283	-243	-189	-226	-212	-206	-205
Additional Paid-In Capital	2.0%	1,060	1,039	1,021	1,009	997	985	972	961	952	943	933	921	977	959	944	883	862	415	399	391	378
Shares Outstanding	0.8%	49.00	49.00	48.00	48.00	48.00	47.00	47.00	47.00	46.00	47.00	46.00	46.00	-	-	-	-	-	-	-	-	-
Float	-	-	-	3,445	-	-	-	2,067	-	-	-	3,792	-	-	-	1,634	-	-	-	2,679	-	-

Cashflow (Last 12 Months)

(In Thousands)

Cashflow (Quarterly)																					(In Thousands)
Description	(%) Q/Q	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1	2018Q4
Cashflow From Operations	-30.6%	-10,665	-8,168	-8,161	-30,764	-4,136	-26,515	-12,206	9,774	-4,651	17,790	7,391	4,178	10,604	-9,570	-10,923	-13,099	-4,191	-2,988	6,602	208	17,128
Share Based Compensation	23.9%	12,987	10,484	9,873	10,184	11,688	9,411	10,539	6,923	7,225	6,189	7,984	8,748	8,744	9,660	10,897	17,176	12,470	8,547	8,247	7,129	6,668
Cashflow From Investing	-186.7%	-12,921	14,897	25,951	-13,832	16,655	24,391	9,630	-5,897	-8,872	-26,063	-2,034	-21,263	-3,459	-181,562	-20,667	628	49,812	-4,074	-599	-1,713	-17,752
Cashflow From Financing	-2.2%	7,303	7,467	-880	1,152	529	4,206	106	1,410	1,617	3,867	16,362	17,414	8,659	5,821	243,842	4,220	-22,036	6,666	318	5,407	1,974

GKOS Income Statement

2023-12-31

CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) shares in Thousands, $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
CONSOLIDATED STATEMENTS OF OPERATIONS
Net sales	$ 314,711	$ 282,862	$ 294,011
Cost of sales	75,575	68,979	66,627
Gross profit	239,136	213,883	227,384
Operating expenses:
Selling, general and administrative	224,068	192,925	179,257
Research and development	138,768	123,271	100,999
Acquired in-process research and development	5,000	10,000	10,000
Litigation-related settlement		(30,000)	(30,000)
Total operating expenses	367,836	296,196	260,256
Loss from operations	(128,700)	(82,313)	(32,872)
Non-operating expense:
Interest income	9,164	2,375	1,288
Interest expense	(13,633)	(13,720)	(13,372)
Other expense, net	(558)	(4,771)	(4,311)
Total non-operating expense	(5,027)	(16,116)	(16,395)
Loss before taxes	(133,727)	(98,429)	(49,267)
Income tax provision	934	766	326
Net loss	$ (134,661)	$ (99,195)	$ (49,593)
Basic net loss per share (in dollar per share)	$ (2.78)	$ (2.09)	$ (1.07)
Diluted net loss per share (in dollar per share)	$ (2.78)	$ (2.09)	$ (1.07)
Weighted average shares outstanding used to compute basic net loss per share	48,433	47,444	46,423
Weighted average shares outstanding used to compute diluted net loss per share	48,433	47,444	46,423

GKOS Balance Sheet

2023-12-31

CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Dec. 31, 2023	Dec. 31, 2022
Current assets:
Cash and cash equivalents	$ 93,467	$ 119,525
Short-term investments	201,964	233,170
Accounts receivable, net	39,850	36,073
Inventory	41,986	37,841
Prepaid expenses and other current assets	18,194	17,250
Total current assets	395,461	443,859
Restricted cash	5,856	7,078
Property and equipment, net	103,212	94,403
Operating lease right-of-use assets	27,146	25,826
Finance lease right-of-use asset	44,180	46,601
Intangible assets, net	282,956	307,869
Goodwill	66,134	66,134
Deposits and other assets	15,469	10,613
Total assets	940,414	1,002,383
Current liabilities:
Accounts payable	13,440	14,403
Accrued liabilities	60,574	57,956
Total current liabilities	74,014	72,359
Convertible senior notes	282,773	281,400
Operating lease liability	30,427	28,905
Finance lease liability	70,538	72,172
Deferred tax liability, net	7,144	7,264
Other liabilities	13,752	10,278
Total liabilities	478,648	472,378
Commitments and contingencies (Note 12)
Stockholders' equity:
Preferred stock, $0.001 par value; 5,000 shares authorized; no shares issued or outstanding as of December 31, 2023 and 2022
Common stock, $0.001 par value; 150,000 shares authorized; 49,148 and 47,782 shares issued and 49,120 and 47,754 shares outstanding as of December 31, 2023 and 2022, respectively	49	48
Additional paid-in capital	1,059,751	997,470
Accumulated other comprehensive income (loss)	1,165	(2,975)
Accumulated deficit	(599,067)	(464,406)
Less treasury stock (28 shares as of December 31, 2023 and 2022)	(132)	(132)
Total stockholders' equity	461,766	530,005
Total liabilities and stockholders' equity	$ 940,414	$ 1,002,383

About Glaukos Corp

Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-to-moderate open-angle glaucoma. The company's product pipeline includes iStent Infinite, an implantable device intended to reduce the intraocular pressure of the eye; and iDose TR, a targeted injectable implant based on its micro-scale device-platform that is designed to deliver therapeutic levels of medication. The company markets its products through direct sales organization, as well as through distributors in the United States and internationally. Glaukos Corporation was incorporated in 1998 and is headquartered in Aliso Viejo California.

CEO	Mr. Thomas William Burns
WEBSITE	glaukos.com
INDUSTRY	Medical Instruments & Supplies
EMPLOYEES	783

Glaukos Corp Frequently Asked Questions

What is the ticker symbol for Glaukos Corp? What does GKOS stand for in stocks?

GKOS is the stock ticker symbol of Glaukos Corp. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Glaukos Corp (GKOS)?

As of Tue Apr 23 2024, market cap of Glaukos Corp is 5 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of GKOS stock?

You can check GKOS's fair value in chart for subscribers.

What is the fair value of GKOS stock?

You can check GKOS's fair value in chart for subscribers. The fair value of Glaukos Corp is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of Glaukos Corp is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for GKOS so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is Glaukos Corp a good stock to buy?

The fair value guage provides a quick view whether GKOS is over valued or under valued. Whether Glaukos Corp is cheap or expensive depends on the assumptions which impact Glaukos Corp's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for GKOS.

What is Glaukos Corp's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Tue Apr 23 2024, GKOS's PE ratio (Price to Earnings) is -37.13 and Price to Sales (PS) ratio is 15.89. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. GKOS PE ratio will change depending on the future growth rate expectations of investors.